RESEARCH-INFORMED GROWTH HEALTH CHECK | PAUL MASON CONSULTING

Before you scale,
know what works

Before you invest in more salespeople, new markets or a larger pipeline, can you show what is already working, and why?

Independent researchBefore we meet
A working conversation90–120 minutes
Two to three weeksSubject to agreed timing
The growth decision

A clearer view before you commit.

For founders facing an important growth decision

Winning customers proves that some buyers value what you have built. It does not prove that you can acquire the next ten in the same way. Before hiring, entering a new market or increasing spend, examine what is genuinely repeatable.

What I bring

I research your business, market, competitors and alternatives before we meet. I bring independent context, commercial judgement and coaching skills, informed by 18 years at Microsoft and advisory work with software businesses. At Solgari, I helped its leadership develop and adopt a strategic shift towards positioning the business as the conversational data layer for AI.

My research may support or challenge your view of the market. We test it against your customer evidence. You own the conclusions and decisions.

What you receive

Research, conversation and time to reflect.

What you receive

  • A short introductory conversation (approximately 20 minutes) to identify the growth decision you want to examine.
  • Independent preparation, using credible public sources and existing business information you choose to share.
  • A focused, 90-120 minute working conversation to examine the evidence and challenge assumptions.
  • A written Growth Health Summary: the decision under consideration, supporting and challenging evidence, important unknowns, external context and questions worth resolving.
  • A 30-45 minute follow-up to reflect on the summary and decide what deserves attention.

I am testing this engagement with a few founders and will ask for feedback. We agree scope, pilot fee and timetable in advance. I aim to complete the work in two to three weeks, subject to availability and receiving agreed information. Further advisory work is optional.

FOUNDER PREPARATION GUIDE

Preparing for our growth conversation

Start with the decision, not a checklist

What is the important commercial choice you expect to make over the next 3-12 months? What would make that choice costly if you were wrong? We will use that question to decide which parts of the business need closer examination. The framework below is a set of prompts, not a rigid agenda.

How the work unfolds

01

1 | Agree the question and available evidence

We identify the decision you want to examine and the existing information that may help. You do not need a new presentation. I will sign your confidentiality agreement before you share anything sensitive.

02

2 | Independent research before the meeting

I review your positioning, customer and partner signals, competing products and alternative ways buyers solve the problem, relevant market developments and public evidence of differentiation. I also review any existing material you share, such as customer examples, pipeline trends or retention information. Where public evidence is thin, I say so rather than treating assumptions as findings. Research is intended to inform the questions, not substitute for your internal evidence.

03

3 | Evidence-led working conversation

We spend approximately 90-120 minutes examining the areas most relevant to your decision. We test what appears repeatable, where evidence is incomplete and what might challenge the prevailing view. You can challenge my interpretations as freely as I challenge yours.

04

4 | Written summary and follow-up

I prepare the written Growth Health Summary and share it before our 30-45 minute follow-up. We use that discussion to explore what the evidence means for the decision you face.

What to bring, if you have it

  • Three to five customers that best represent the business you want to build, and why they bought.
  • Recent wins, losses and stalled opportunities, including reasons you believe deals progressed or failed.
  • Broad pipeline and conversion trends, and where opportunities originate.
  • Customer usage, time to value, renewal, expansion and referrals, where available.
  • The assumptions behind the growth decision you are contemplating.

Existing examples are enough to begin. Please do not send customer identities or sensitive financial information until I have signed your confidentiality agreement.

Evidence before assumptions

The questions we may explore

I start by examining the evidence for product-market fit. I then draw selectively on the seven stages of my Growth Loop to explore how your business finds, wins, serves and grows customers, and learns from the results.

First: product-market fit

What recurring, costly problem do your best customers share? What have they paid, used, renewed or referred? Have you repeated wins without bespoke work, exceptional discounts or disproportionate founder effort?

Focus

Which customer segments and use cases are you pursuing deliberately, and which are you declining?

Position

Why would a buyer change, choose you rather than an alternative, and act now?

Find

Where do qualified opportunities actually originate? How much depends on founder relationships?

Win

What do conversion, deal duration, recent losses and stalled opportunities reveal?

Deliver

How quickly do customers reach a valuable outcome, and how is that evidenced?

Expand

What do renewal, usage, advocacy and expansion tell us about sustained value?

Learn

What changed in the last 90 days because of what customers actually did?

Two questions apply throughout: What evidence supports that belief? What evidence might challenge it?

The written summary

The written summary: what it looks like

The fictional example below shows the kind of evidence and questions I would organise in the summary. Actual findings depend on the information available.

Illustrative Growth Health Summary

FICTIONAL EXAMPLE | B2B WORKFLOW SOFTWARE COMPANY

Decision being considered

Should the founder hire two account executives to accelerate growth over the next six months?

Evidence supporting the decision

  • Of 11 paying customers, six are in the same operational niche and report a similar recurring problem.
  • Four of those customers renewed, and three expanded usage within their first year.
  • Recent opportunities show buyers will pay for the product without substantial customisation.

Evidence challenging the decision

  • Seven of the last nine wins involved the founder directly in discovery and closing.
  • Most new opportunities originated through introductions, with limited evidence of a repeatable prospecting channel.
  • Two stalled deals suggest the value proposition may be less compelling outside the initial niche.

External perspective to examine

A review of competitors and alternative workflows suggests differentiation may be strongest in one use case rather than across the broader market. This is a research hypothesis to test with customer evidence.

Important unknowns

  • Can a salesperson independently qualify and close a customer in the target niche?
  • Is the current conversion rate sustained when founder-led opportunities are excluded?
  • How much of the sales cycle depends on product work or bespoke implementation?

Questions for the founder’s decision

What evidence would justify hiring two account executives now, and what could be learned before making that commitment? What risks would you be comfortable accepting?

Founder’s reflection and next decision

To be completed with the founder in the follow-up discussion. I will not make the decision on your behalf.

How to start

Start with a 20-minute conversation.

Contact me at paulmasonconsult.com with a few lines about your business and the decision ahead. We can start with a 20-minute conversation.

Email Paul →